Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Novartis presents novel inhibitors of hepatocyte growth factor receptor

March 11, 2011

PharmaMar reports novel inhibitors of HIV reverse transcriptase

March 11, 2011

Phenex Pharma patents new farnesoid X receptor agonists

March 11, 2011

Merck & Co. presents novel renin inhibitors

March 11, 2011

New FGFR-2 activators reported by sanofi-aventis

March 10, 2011

Mitsubishi Tanabe and sanofi-aventis present new GSK-3 beta inhibitors

March 10, 2011

Anacor Pharma synthesizes new boron-containing antiprotozoal agents

March 10, 2011

Basilea Pharma patents new inhibitors of cAMP-specific 3',5'-cyclic phosphodiesterase 4

March 10, 2011

Novel inhibitors of HCV RNA replication designed at Tibotec

March 9, 2011

GSK patents new activators of Toll-like receptor 7 and/or 8

March 9, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...